Aprea Therapeutics, Inc. · NASDAQ:APRE
LYTTON LAURENCE W reported a 3.20% stake in Aprea Therapeutics, Inc. (Schedule 13G/A)
Event Jun 30, 2026 · Filed Aug 13, 2026
LYTTON LAURENCE W reported a 3.20% stake in Aprea Therapeutics, Inc., 390,807 shares, as a passive investor on Jun 30, 2026. Filed Aug 13, 2026 (Schedule 13G/A).
- Stake
- 3.20%
- Shares
- 390,807
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| LYTTON LAURENCE W | 3.20% | 390,807 |
Source
Related
- Aprea Therapeutics, Inc.
- Laurence W. Lytton
- Aprea Therapeutics, Inc. shareholders
- Schedule 13G · Laurence W. Lytton · Nov 17, 2025
- Form 4 · Grissinger Michael · Jun 17, 2026
- Form 4 · Gruia Gabriela · Jun 17, 2026
- Form 4 · Peters Richard · Jun 17, 2026
- Form 4 · Henneman John B III · Jun 17, 2026
- Form 4 · Bizzari Jean-Pierre · Jun 17, 2026